Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Brello Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxBrello Health
Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate.
Visit Brello HealthThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 64. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Brello Health still earns a C — Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Brello Health |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 64/100 |
| Semaglutide / mo | $99/mo | $133/mo (3-month plan, compounded) |
| Tirzepatide / mo | $149/mo | $166/mo (3-month plan, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,596 |
| Tirzepatide / yr (modeled) | $1,788 | $1,992 |
| Coverage | All 50 states | 35 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #175 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Brello Health
64/100Where the value is
- Discount structure is itemized transparently — both the discounted and pre-discount standing price are shown side by side ($133 vs $198 for semaglutide, $166 vs $247 for tirzepatide)
- Bundle options combining GLP-1 with NAD+ and/or Sermorelin are available on the same subscription
- The commitment mechanics are explicitly disclosed on-site ('3-month minimum commitment and automatically renew every 11 weeks') rather than buried in terms of service
The tradeoffs
- No month-to-month option exists at any price — every plan requires a 3-month minimum and auto-renews every 11 weeks, a real commitment a shopper comparing 'per month' prices across sites could easily miss
- The compounding pharmacy is not named, only 'USA-based 503A Partner Pharmacy,' and the site discloses it is mid-transition to a new facility
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.